Business
Biotech Firm Amyris Hit with $881M Suit over Cannabinoid IP
By
Willis Jacobson
Sep 17, 2020
Sep 17, 2020
Share: 
A cannabinoid manufacturer has sued biotech company Amyris for $881M, amid a fraught 18-months relationship between the companies. Among other allegations, the lawsuit claims Amyris used the partnership to artificially inflate its own value and then leveraged the plaintiff’s trade...
This content is FREE for registered users.
To view this content you need to register as a Weedweek member.
If you are already a member please login below.
Share:
pro
“A plant divided:” Can weed and hemp get along?
A few weeks ago, the founder and CEO of savory California edibles brand Tsumo Snacks said she was leaving her company and the licensed weed market. “What I truly want...
business
Trulieve worker died of occupational asthma: Report
A report from state and federal regulators determined that 27-year old Trulieve worker Lorna McMurrey was the industry's first occupational asthma reported fatality. McMurrey collapsed during a January 2022 shift...
business
SCOOP: Berner discussed past “pimping experiences” in 2019 video
Cookies CEO Berner discussed past “pimping experiences,” in a 2019 podcast appearance. The exchange came towards the end of a wide-ranging conversation about his rise to become a prominent rapper...
